130016-75-0 Usage
Derivative of propionic acid
The compound is derived from propionic acid, which is a short-chain fatty acid.
Contains a pyrrole ring
The compound has a pyrrole ring, which is a five-membered aromatic ring with four carbon atoms and one nitrogen atom.
Contains a phenyl group
The compound has a phenyl group, which is a six-membered aromatic ring with six carbon atoms.
Non-steroidal anti-inflammatory drug (NSAID)
The compound is commonly used as an NSAID to relieve pain and reduce inflammation.
Potential use in treating cancer
The compound is being investigated for its potential use in treating certain types of cancer.
Modulating the endocannabinoid system
The compound has been studied for its potential role in modulating the endocannabinoid system, which is a complex system in the body that plays a role in maintaining homeostasis.
Effects on the central nervous system
The compound has been studied for its potential effects on the central nervous system.
Check Digit Verification of cas no
The CAS Registry Mumber 130016-75-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,0,0,1 and 6 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 130016-75:
(8*1)+(7*3)+(6*0)+(5*0)+(4*1)+(3*6)+(2*7)+(1*5)=70
70 % 10 = 0
So 130016-75-0 is a valid CAS Registry Number.
130016-75-0Relevant articles and documents
Methods for treating leukemia and myelodysplastic syndrome, and methods for identifying agents for treating same
-
, (2009/05/29)
The present disclosure relates to methods for treating leukemia, pre-leukemic conditions, as well as myelodysplastic syndrome and acute myelogenous leukemia. The present disclosure further relates to compounds that can be used for treating leukemia, pre-leukemic conditions, as well as myelodysplastic syndrome and acute myelogenous leukemia. The present disclosure also relates to methods for identifying compounds that can be used for treating leukemia, pre-leukemic conditions, as well as myelodysplastic syndrome.
